Reversal of Cognitive Decline (ReCODE): a prospective observational study using a comprehensive lifestyle-related protocol— supported end-to-end by QuesGen as CRO and platform partner.
Developed by UCSF-trained neurologist Dale Bredesen, the ReCODE study explored a comprehensive lifestyle-related protocol to reverse neurocognitive decline for patients with Alzheimer’s—considering inflammation, environmental toxins, gut health, and other factors such as diet, exercise, sleep, and stress.
Working closely with the research team, QuesGen delivered a proven data model, development tools, and research processes to support rapid prototyping and piloting—helping the team conduct research more efficiently, with less systematic risk and greater accuracy.
QuesGen developed a screening and enrollment process to reduce participant burden and ensure participants meeting requirements were scheduled efficiently. The team also supported participant outreach via a portal with electronic surveys and ePRO/EMA reminders.
ReCODE required coordination, protocol rigor, and data quality controls—without slowing down the team. QuesGen’s combination of CRO services and a proven brain health research platform made it possible to run the study with less friction and more confidence.
If your study needs both operational rigor (IRB/protocol work, participant tracking, vendor/site coordination) and a flexible platform for validated longitudinal capture, this combination can reduce risk and speed execution.
Whether you’re running a multi-site study, building a population health program, or enabling person-centered care, QuesGen delivers planning, tracking, and outcomes measurement on one coherent platform.